Global Transcatheter Aortic Valve Replacement (TAVR) Market 2025 by Company, Regions, Type and Application, Forecast to 2031
Description
According to our (Global Info Research) latest study, the global Transcatheter Aortic Valve Replacement (TAVR) market size was valued at US$ 9024 million in 2024 and is forecast to a readjusted size of USD 18060 million by 2031 with a CAGR of 10.5% during review period.
Transcatheter Aortic Valve Replacement (TAVR), also referred as Transcatheter Aortic Valve Implantation (TAVI) is a minimally invasive surgical procedure repairs the valve without removing the old, damaged valve. Instead, it wedges a replacement valve into the aortic valve's place. Normally valve replacement method requires an open heart procedure with a sternotomy, in which the chest is surgically separated for the treatment. The TAVR procedures can be done through very small openings that leave all the chest bones in place.
The Transcatheter Aortic Valve Replacement (TAVR) market is primarily driven by the increasing prevalence of aortic stenosis and the growing aging population worldwide. As people live longer, the incidence of age-related cardiovascular conditions, such as aortic valve disease, is on the rise. TAVR offers a minimally invasive alternative to traditional open-heart surgery, making it a highly attractive option for elderly patients or those with high surgical risk. Additionally, technological advancements in TAVR devices, such as improved valve designs, delivery systems, and procedural techniques, have contributed to enhanced patient outcomes and safety, further expanding the market. The increasing acceptance of TAVR as a first-line treatment, even for intermediate-risk patients, also fuels market growth.
However, the TAVR market faces several challenges, primarily the high cost of the procedure and devices. Despite its advantages, TAVR is still a relatively expensive treatment, which can limit its accessibility, particularly in low- and middle-income countries or healthcare systems with constrained budgets. Furthermore, the long-term durability of TAVR valves remains a concern for both physicians and patients, as the procedure is relatively new compared to traditional surgical valve replacements. Ongoing research and clinical trials are needed to better understand the long-term outcomes of TAVR, which could influence its adoption and cost-effectiveness in the future.
Edwards Lifesciences, Medtronic, Abbott, Boston Scientific, Meril Life Sciences, etc. are the leaders of the industry, Top 5 compnay market share are about 90%
This report is a detailed and comprehensive analysis for global Transcatheter Aortic Valve Replacement (TAVR) market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Transcatheter Aortic Valve Replacement (TAVR) market size and forecasts, in consumption value ($ Million), 2020-2031
Global Transcatheter Aortic Valve Replacement (TAVR) market size and forecasts by region and country, in consumption value ($ Million), 2020-2031
Global Transcatheter Aortic Valve Replacement (TAVR) market size and forecasts, by Type and by Application, in consumption value ($ Million), 2020-2031
Global Transcatheter Aortic Valve Replacement (TAVR) market shares of main players, in revenue ($ Million), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Transcatheter Aortic Valve Replacement (TAVR)
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Transcatheter Aortic Valve Replacement (TAVR) market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Edwards Lifesciences, Medtronic, Abbott, Boston Scientific, Meril Life Sciences, Venus Medtech, Bracco (HLT), JenaValve Technology, Suzhou Jiecheng Medical Technology Co., Peijia Medical, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market segmentation
Transcatheter Aortic Valve Replacement (TAVR) market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Transfemoral Approach
Transapical Approach
Others
Market segment by Application
Aortic Stenosis
Aortic Regurgitation
Others
Market segment by players, this report covers
Edwards Lifesciences
Medtronic
Abbott
Boston Scientific
Meril Life Sciences
Venus Medtech
Bracco (HLT)
JenaValve Technology
Suzhou Jiecheng Medical Technology Co.
Peijia Medical
MicroPort
Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Transcatheter Aortic Valve Replacement (TAVR) product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Transcatheter Aortic Valve Replacement (TAVR), with revenue, gross margin, and global market share of Transcatheter Aortic Valve Replacement (TAVR) from 2020 to 2025.
Chapter 3, the Transcatheter Aortic Valve Replacement (TAVR) competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2020 to 2031
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2020 to 2025.and Transcatheter Aortic Valve Replacement (TAVR) market forecast, by regions, by Type and by Application, with consumption value, from 2026 to 2031.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Transcatheter Aortic Valve Replacement (TAVR).
Chapter 13, to describe Transcatheter Aortic Valve Replacement (TAVR) research findings and conclusion.
Transcatheter Aortic Valve Replacement (TAVR), also referred as Transcatheter Aortic Valve Implantation (TAVI) is a minimally invasive surgical procedure repairs the valve without removing the old, damaged valve. Instead, it wedges a replacement valve into the aortic valve's place. Normally valve replacement method requires an open heart procedure with a sternotomy, in which the chest is surgically separated for the treatment. The TAVR procedures can be done through very small openings that leave all the chest bones in place.
The Transcatheter Aortic Valve Replacement (TAVR) market is primarily driven by the increasing prevalence of aortic stenosis and the growing aging population worldwide. As people live longer, the incidence of age-related cardiovascular conditions, such as aortic valve disease, is on the rise. TAVR offers a minimally invasive alternative to traditional open-heart surgery, making it a highly attractive option for elderly patients or those with high surgical risk. Additionally, technological advancements in TAVR devices, such as improved valve designs, delivery systems, and procedural techniques, have contributed to enhanced patient outcomes and safety, further expanding the market. The increasing acceptance of TAVR as a first-line treatment, even for intermediate-risk patients, also fuels market growth.
However, the TAVR market faces several challenges, primarily the high cost of the procedure and devices. Despite its advantages, TAVR is still a relatively expensive treatment, which can limit its accessibility, particularly in low- and middle-income countries or healthcare systems with constrained budgets. Furthermore, the long-term durability of TAVR valves remains a concern for both physicians and patients, as the procedure is relatively new compared to traditional surgical valve replacements. Ongoing research and clinical trials are needed to better understand the long-term outcomes of TAVR, which could influence its adoption and cost-effectiveness in the future.
Edwards Lifesciences, Medtronic, Abbott, Boston Scientific, Meril Life Sciences, etc. are the leaders of the industry, Top 5 compnay market share are about 90%
This report is a detailed and comprehensive analysis for global Transcatheter Aortic Valve Replacement (TAVR) market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Transcatheter Aortic Valve Replacement (TAVR) market size and forecasts, in consumption value ($ Million), 2020-2031
Global Transcatheter Aortic Valve Replacement (TAVR) market size and forecasts by region and country, in consumption value ($ Million), 2020-2031
Global Transcatheter Aortic Valve Replacement (TAVR) market size and forecasts, by Type and by Application, in consumption value ($ Million), 2020-2031
Global Transcatheter Aortic Valve Replacement (TAVR) market shares of main players, in revenue ($ Million), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Transcatheter Aortic Valve Replacement (TAVR)
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Transcatheter Aortic Valve Replacement (TAVR) market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Edwards Lifesciences, Medtronic, Abbott, Boston Scientific, Meril Life Sciences, Venus Medtech, Bracco (HLT), JenaValve Technology, Suzhou Jiecheng Medical Technology Co., Peijia Medical, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market segmentation
Transcatheter Aortic Valve Replacement (TAVR) market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Transfemoral Approach
Transapical Approach
Others
Market segment by Application
Aortic Stenosis
Aortic Regurgitation
Others
Market segment by players, this report covers
Edwards Lifesciences
Medtronic
Abbott
Boston Scientific
Meril Life Sciences
Venus Medtech
Bracco (HLT)
JenaValve Technology
Suzhou Jiecheng Medical Technology Co.
Peijia Medical
MicroPort
Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Transcatheter Aortic Valve Replacement (TAVR) product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Transcatheter Aortic Valve Replacement (TAVR), with revenue, gross margin, and global market share of Transcatheter Aortic Valve Replacement (TAVR) from 2020 to 2025.
Chapter 3, the Transcatheter Aortic Valve Replacement (TAVR) competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2020 to 2031
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2020 to 2025.and Transcatheter Aortic Valve Replacement (TAVR) market forecast, by regions, by Type and by Application, with consumption value, from 2026 to 2031.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Transcatheter Aortic Valve Replacement (TAVR).
Chapter 13, to describe Transcatheter Aortic Valve Replacement (TAVR) research findings and conclusion.
Table of Contents
116 Pages
- 1 Market Overview
- 2 Company Profiles
- 3 Market Competition, by Players
- 4 Market Size Segment by Type
- 5 Market Size Segment by Application
- 6 North America
- 7 Europe
- 8 Asia-Pacific
- 9 South America
- 10 Middle East & Africa
- 11 Market Dynamics
- 12 Industry Chain Analysis
- 13 Research Findings and Conclusion
- 14 Appendix
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
